Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-02-21
1998-09-22
Travers, Russell
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A01N 4364, A61K 3144
Patent
active
058114424
ABSTRACT:
Patients suffering from or susceptible to conditions of the vascular or circulatory system, particularly the microvasculature, which conditions are associated with decreased blood flow in regions of microcirculation (e.g., Raynaud's disease and Raynaud's phenomenon) are treated with pharmaceutical compositions incorporating an effective amount of an aryl substituted olefinic amine compound. The compounds incorporated into the pharmaceutical compositions of the present invention exhibit selective activity of to the .beta.2-containing nicotinic acetylcholine receptors and thereby yield beneficial therapeutic effects increasing vascular blood flow in regions of microcirculation.
REFERENCES:
patent: 5212188 (1993-05-01), Caldwell et al.
patent: 5585388 (1996-12-01), Cosford et al.
patent: 5597919 (1997-01-01), Dull et al.
patent: 5604231 (1997-02-01), Smith et al.
patent: 5616707 (1997-04-01), Crooks et al.
patent: 5616716 (1997-04-01), Dull et al.
Bencherif et al., "RJR-2403: A Nicotine Agonist with CNS Selectivity I. In Vivo Characterization", J. of Pharmacology and Exper. Therapeutics, 279(3):1413-1421 (1996).
Henrich et al.; "Microcirculatory Effects of Nicotine and Related Alkaloids"; Kim Wochenschr, 62(Suppl II): 92-100 (1984).
Wilson, Jr. et al.; "Nicotine-Like Actions of cis-Metanicotine and trans-Metanicotine"; J. of Pharmacology and Exper. Therapeutics, 196(3):685-696 (1976).
LaForge, "The Preparation and Properties of Some New Derivatives of Pyridine"; J. Amer. Chem. Soc. 50:2477-2483 (1928).
Acheson et al.; "Transformations involving the Pyrrolidine Ring of Nicotine"; J. Chem. Soc., Perkins Trans., 1:579-585 (1980).
Bencherif et al.; "RJR-2403: A Nicotine Agonist with CNS Selectivity I. In Vitro Characterization"; J. of Pharmacology and Exper. Therapeutics, 279(3):1413-1421 (1996).
Lippiello et al.; "RJR-2403: A Nicotine Agonist with CNS Selectivity II. In Vivo Characterization"; J. of Pharmacology and Exper. Therapeutics, 279(3):1422-1429 (1996).
Jinno et al.; "Nicotine and acetylcholine induce release of calcitonin gene-related peptide from rat trachea"; Amer. Physiological Soc., 1651-1656 (1994).
Bencherif Merouane
Lippiello Patrick Michael
Jones Dwayne C.
Travers Russell
LandOfFree
Pharmaceutical compositions for the treatment of conditions asso does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical compositions for the treatment of conditions asso, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions for the treatment of conditions asso will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1622087